New York, March 05, 2015 -- Moody's Investors Service downgraded BioScrip, Inc.'s ("BioScrip") Corporate Family Rating to Caa1 from B3 and Probability of Default Rating to Caa1-PD from B3-PD. Moody's also downgraded the ratings on the company's senior secured credit facilities to B2 from B1 and affirmed the Caa2 rating on the company's senior unsecured notes. The rating outlook is stable. Concurrently, the company's Speculative Grade Liquidity Rating was lowered to SGL-4 from SGL-3.
Vollständigen Artikel bei Moodys lesen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.